SUBSCRIBE
SUBSCRIBE

Novartis

NEWS
Biotech Bay
Can The Man From Heinz Keep Novartis AG On Top?
February 9, 2012
 · 
1 min read
Biotech Bay
In Memory of Steve Jobs, Novartis Pharmaceuticals Corporation Pushes iPad
October 6, 2011
 · 
1 min read
BioForest
Drugmakers Including Novartis AG Gear Up to Copy Biotech Drugs in U.S.
May 12, 2011
 · 
1 min read
Genetown
Drug Makers Including Genzyme Corporation and Novartis AG See Gains in Broadening their Reach; Focus Shifts to Underserved Patient Groups, Expanded Disease Targets
May 4, 2011
 · 
1 min read
Pharm Country
Novartis AG CEO Not Thrilled With Health Care Reform
May 3, 2011
 · 
1 min read
Pharm Country
Drugmakers Including Merck & Co., Inc. and Novartis AG Create Mobile Phone Apps to Track Diabetes, Cancer
February 15, 2011
 · 
1 min read
Biotech Beach
Drugmakers, Including AstraZeneca PLC, Novartis AG and Eli Lilly and Company See Pain from Reform and Prices in 2011
January 28, 2011
 · 
1 min read
Genetown
At Novartis AG, a Winning Formula
January 4, 2011
 · 
1 min read
Look Out, Your Medicine Is Watching You, Novartis AG Reveals
November 10, 2010
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
July 2, 2026
 · 
7 min read
Press Releases
Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies
June 24, 2026
 · 
2 min read
Press Releases
Novartis Canada and SP Quebec Celebrate 16 Years of Partnership Through Annual MS Tri-Challenge Fundraiser
June 24, 2026
 · 
4 min read
Press Releases
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
June 17, 2026
 · 
2 min read
Press Releases
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
June 12, 2026
 · 
11 min read
Press Releases
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
June 11, 2026
 · 
8 min read
Press Releases
Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines
June 10, 2026
 · 
2 min read
Press Releases
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
June 8, 2026
 · 
6 min read
Press Releases
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
June 4, 2026
 · 
11 min read
Press Releases
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
June 4, 2026
 · 
10 min read
Load More